Clinical,Molecular,and Computational Analysis in Patients With a Novel Double Mutation and a New Synonymous Variant in MeCP2: Report of the First Missense Mutation Within the AT-hook1 Cluster in Rett Syndrome

Abstract

Rett syndrome is an X-linked neurodevelopmental disorder, primarily caused by MECP2 mutations. In this study, clinical, molecular and bioinformatics analyses were performed in Rett patients to understand the relationship between MECP2 mutation type and the clinical severity. Two double MeCP2 mutations were detected: a novel one (p.G185 V in cis with p.R255X) in P1 and a known one (p.P179 S in cis with p.R255X) in P2. Besides, a novel synonymous mutation (c.807C>T; p.G269G), which could affect mRNA splicing, was identified in P3. The results from clinical severity analysis have shown that P1 was more severely affected than P2 with CSS being 35 and 14, respectively. Therefore, the phenotypic variability in P1 and P2 could be explained by the potential pathogenic effect of the RTT-causing missense mutation p.G185 V in the AT-hook1. In conclusion, clinical, molecular, and in silico investigations in the studied patients have been proven to be substantial for the genotype-phenotype correlation.

Keywords

Rett syndrome p.G185 V AT-hook1 chromosome X inactivation

Get full access to this article

View all access options for this article.

References

Amir

Van den Veyver

Wan

Tran

Francke

Zoghbi

. Rett syndrome is caused by mutations in X-linked MECP2 encoding methyl-CpG-binding protein 2. Nat Genet. 1999;23:185–188.

Laurvick

Klerk

Bower

. Rett syndrome in Australia: a review of the epidemiology. J Pediatr. 2006;148:347–352.

Mnatzakanian

Lohi

Munteanu

. A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nat Genet. 2004;36:339–341.

Hansen

Ghosh

Woodcock

. Binding of the Rett syndrome protein, MeCP2, to methylated and unmethylated DNA and chromatin. IUBMB Life. 2010;62:732–738.

Baker

Chen

Wilkins

Lichtarge

Zoghbi

. An AT-Hook domain in MeCP2 determines the clinical course of Rett syndrome and related disorders. Cell. 2013;152:984–996.

Reeves

Nissen

. The AT-DNA-binding domain of mammalian high mobility group I chromosomal proteins. A novel peptide motif for recognizing DNA structure. J Biol Chem. 1990;265:8573–8582.

Stenson

Mort

Ball

Shaw

Phillips

Cooper

. Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet. 2014;133:1–9.

Christodoulou

Grimm

Maher

Bennetts

. RettBASE: the IRSA MECP2 variation database a new mutation database in evolution. Hum Mutat. 2003;21:466–472.

Bedogni

Rossic

Gallia

. Rett syndrome and the urge of novel approaches to study MeCP2 functions and mechanisms of action. Neurosci Biobehav Rev. 2014;46:187–201.

10.

Sheikh

Mittal

Willis

Vincent

. A synonymous change, p.Gly16Gly in MECP2 Exon1, causes a cryptic splice event in a Rett syndrome patient. Orphanet J Rare Dis. 2013;8:108.

11.

Chapleau

Lane

Kirwin

. Detection of rarely identified multiple mutations in MECP2 gene do not contribute to enhanced severity in Rett syndrome. Am J Med Genet A. 2013;161A:1638–1646.

12.

Das

Raha

Sanghavi

Maitra

Udani

. Spectrum of MECP2 gene mutations in a cohort of Indian patients with Rett syndrome: report of two novel mutations. Gene. 2013;515:78–83.

13.

Ishii

Friedman

. Selective loss of sphingosine 1-phosphate signaling with no obvious phenotypic abnormality in mice lacking its G protein-coupled receptor, LP (B3)/EDG-3. J Biol Chem. 2001;276:33697–33704.

14.

Neul

Kaufmann

Glaze

. RettSearch Consortium. Rett syndrome: revised diagnostic criteria and nomenclature. Ann Neurol. 2010;68:944–950.

15.

Lane

Lee

Smith

. Clinical severity and quality of life in children and adolescents with Rett syndrome. Neurology. 2011;77:1812–1818.

16.

Lewin

Stewart-Haynes

. A simple method for DNA extraction from leukocytes for use in PCR. Biotechniques. 1992;13:522–524.

17.

Fendri-Kriaa

Abdelkafi

Rebeh

Kamoun

Triki

Fakhfakh

. A novel MECP2 gene mutation in a Tunisian patient with Rett syndrome. Genet Test Mol Biomarkers. 2009;13:109–113.

18.

Allen

Zoghbi

Moseley

Rosenblatt

Belmont

. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet. 1992;51:1229–1239.

19.

Siepel

Bejerano

Pedersen

. Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res. 2005;15:1034–1050.

20.

Adzhubei

Schmidt

Peshkin

. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7:248–249.

21.

Schwarz

Rödelsperger

Schuelke

Seelow

. Mutation Taster evaluates disease-causing potential of sequence alterations. Nat Methods. 2010;7:575–576.

22.

Wong

Zhang

. SNPdryad: predicting deleterious non-synonymous human SNPs using only orthologous protein sequences. Bioinformatics. 2010;30:1112–1119.

23.

Shihab

Gough

Cooper

. Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov models. Hum Mutat. 2013;34:57–65.

24.

Desmet

Hamroun

Lalande

Collod-Béroud

Claustres

Béroud

. Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res. 2009;37:e67.

25.

Combet

Blanchet

Geourjon

Deléage

. NPS@: network protein sequence analysis, Trends. Biochem Sci. 2000;25:147–150.

26.

Kharrat

Hsairi

Fendri-Kriaa

. A novel mutation p. A59P in N-terminal domain of methyl-CpG-binding protein 2 confers phenotypic variability in 3 cases of Tunisian Rett patients: clinical evaluations and in silico investigations. J Child Neurol. 2015;30:1715–1721.

27.

Venselaar

Joosten

Vroling

. Homology modelling and spectroscopy, a never-ending love story. Eur Biophys J. 2010;39:551–563.

28.

Weaving

Williamson

Bennetts

. Effects of MECP2 mutation type, location and X-inactivation in modulating Rett syndrome phenotype. Am J Med Genet A. 2003;118A:103–114.

29.

Bianciardi

Fichera

Failla

. MECP2 missense mutations outside the canonical MBD and TRD domains in males with intellectual disability. J Hum Genet. 2016;6:95–101.

30.

Miyake

Yang

Minakuchi

. Comparison of genomic and epigenomic expression in monozygotic twins discordant for Rett syndrome. PLOS ONE. 2013;8:e66729.

31.

Lyst

Connelly

Merusi

Bird

. Sequence-specific DNA binding by AT-hook motifs in MeCP2. FEBS Lett. 2016;590:2927–2933.

32.

Bunyan

Robinson

. Multiple de novo mutations in the MECP2 gene. Genet Test. 2008;12:373–375.

33.

Fendri-Kriaa

Hsairi

Kifagi

. A case of a Tunisian Rett patient with a novel double-mutation of the MECP2 gene. Biochem Biophys Res Commun. 2011;409:270–274.

34.

Fendri-Kriaa

Rouissi

Ghorbel

. Novel double deletions in the MECP2 gene in Tunisian Rett patient. Gene. 2012;502:163–167.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.36 MB